{
  "resourceType" : "ConceptMap",
  "id" : "who-ddcc-map-cvx-icd11-brands",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ConceptMap who-ddcc-map-cvx-icd11-brands</b></p><a name=\"who-ddcc-map-cvx-icd11-brands\"> </a><a name=\"hcwho-ddcc-map-cvx-icd11-brands\"> </a><a name=\"who-ddcc-map-cvx-icd11-brands-en-US\"> </a><p>Mapping from (not specified) to (not specified)</p><br/><p><b>Group 1 </b>Mapping from <a href=\"CodeSystem-WHODDCCcvx.html\">CVX codes used in this IG</a> to <code>http://id.who.int/icd11/mms</code></p><table class=\"grid\"><tr><td><b>Source Code</b></td><td><b>Relationship</b></td><td><b>Target Code</b></td></tr><tr><td>208 (SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose)</td><td><a href=\"http://hl7.org/fhir/extensions/5.1.0/CodeSystem-concept-map-equivalence.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>XM8NQ0</td></tr></table></div>"
  },
  "url" : "http://smart.who.int/ddcc/ConceptMap/who-ddcc-map-cvx-icd11-brands",
  "version" : "1.0.0",
  "name" : "ICD11_SNOMED_CT_COVID19_brands",
  "title" : "ConceptMap from CVX to ICD-11 for Brands",
  "status" : "draft",
  "experimental" : true,
  "date" : "2022-05-23",
  "publisher" : "WHO",
  "contact" : [{
    "name" : "WHO",
    "telecom" : [{
      "system" : "url",
      "value" : "http://who.int"
    }]
  }],
  "description" : "Rule-based mappings between CVX and ICD-11 and for COVID-19 Brands",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "001"
    }]
  }],
  "group" : [{
    "source" : "http://hl7.org/fhir/sid/cvx",
    "target" : "http://id.who.int/icd11/mms",
    "element" : [{
      "code" : "208",
      "target" : [{
        "code" : "XM8NQ0",
        "equivalence" : "equivalent"
      }]
    }],
    "unmapped" : {
      "mode" : "provided"
    }
  }]
}